TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

NCT00867568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma
Medulloblastoma
Relapse

Interventions

DRUG: TPI 287

Sponsor

Giselle Sholler

Collaborators

[object Object]